Tregs, a critical subset of CD4+ T cells that are characterized by the CD4+CD25+FoxP3+ phenotype, play the role of negative immune regulation in solid tumors and hematological malignancies (44). This evidence concerns the gene FOXP3 and hematologic disorder.